Inflammatory bowel disease (IBD) pathogenesis is associated with gut mucosal
inflammation, epithelial damage, and dysbiosis leading to a dysregulated gut mucosal …

The inflammatory bowel disease (IBD) is incurable, chronic, recrudescent disorders in the
inflamed intestines. Current clinic treatments are challenged by systemic exposure-induced …

Traditional drug-based treatments for inflammatory bowel disease (IBD) have significant
limitations due to their potential off-target systemic side-effects. Currently, there is a lack of …

The exciting success of NBTXR3 in the clinic has triggered a tumult of activities in the design
and development of hafnium-based nanoparticles. However, due to the concerns of …

Possessing the largest surface area of mucosa in the body, the gastrointestinal (GI) tract can
easily sufferfrom inflammatory damage under various adverse external exposures, resulting …

Dendrimers are a family of polymers with highly branched structure, well‐defined
composition, and extensive functional groups, which have attracted great attention in …

Despite the progress in the therapy of ulcerative colitis (UC), long-lasting UC remission can
hardly be achieved in the majority of UC patients. The key pathological characteristics of UC …

Gastrointestinal (GI) tract, which possesses the largest surface area of mucosa in the body,
is easily suffered from inflammatory damages under the exposure of external stimulations …

Ulcerative colitis (UC) as an important type of inflammatory bowel disease is a chronic
disease characterized by intestinal dyshomeostasis. The UC treatment is challenged by the …

The pathogenesis of inflammatory bowel diseases (IBDs) including ulcerative colitis (UC)
and Crohn's disease is extremely cloudy. Maintaining the level of remission lesions in colitis …